canopy growth

Canopy Growth: New Cannabis 2.0 Products amid COVID-19

Canopy Growth (NYSE:CGC)(TSE:WEED) still has investors' attention despite all that the marijuana industry has gone through.
tilray

What Do Analysts Think about Tilray after Its Q1 Results?

Tilray (NASDAQ:TLRY) posted its first-quarter earnings on May 11. The revenue growth was impressive in the first quarter.
curaleaf

Why Did Curaleaf Report a Mixed Q1 Performance?

On Monday, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings after the market closed. The company reported revenue of $96.5 million.
hexo

Hexo Receives NYSE Warning for Listing, Clock Is Ticking

On April 7, the NYSE sent a listing notification to Hexo. The warning said that the stock fell below the NYSE's $1.00 share price continued listing standard.
Aurora Cannabis

Why Aurora Cannabis Stock Surged 68% on May 15

Aurora Cannabis (NYSE:ACB) reported its third-quarter results on May 14. The earnings report was a surprise for most analysts and investors.
green thumb

Green Thumb Industries Had a Good Start to Fiscal 2020

Green Thumb Industries reported impressive results for the first quarter of fiscal 2020 on Thursday after the market closed.
marijuana

Could Marijuana Legalization Help Texas Recover Its Losses?

Texas has suffered huge economic losses. Many industry experts think that marijuana legalization could be a good option to revive the state's economy.
aurora cannabis

Aurora Cannabis: Q3 Revenue Beat the Estimates

Aurora Cannabis saw less of an impact from COVID-19 in the third quarter. Cannabis is an essential item amid the pandemic.
Curaleaf

Why Curaleaf Is a ‘Buy’ before Its Q1 Earnings

Analysts expect Curaleaf's EBITDA to rise during the quarter. They expect the company to report an EBITDA of $15.7 million.